Campaigns to require the labeling of GM foods are starting to heat up, with the number of countries requiring disclosure now up to 50.
I was fascinated to read Cookson Beecher's Food Safety News' analysis of current campaigns to label genetically modified foods (GMOs).
It brought back memories of the time I served as an obviously ignored consumer representative on the Food and Drug Administration's Food Advisory Committee. Back in the early 1990s, the FDA formed this committee to get advice on issues that might be controversial. It asked us for advice about whether to approve GM foods and, if so, whether they should be labeled.
We learned later that the FDA was using the committee to give it a heads up on decisions that were already made. The FDA had every intention of approving GMOs (I wrote about this in my book Safe Food: The Politics of Food Safety).
I and the other three consumer representatives argued as strongly as we could that labeling was essential:
- Consumers have a right to know.
- Consumers want to know (polls showed this overwhelmingly, even in 1994).
- Not-labeling will induce distrust of biotech foods and the biotech industry.
- Not-labeling will end up hurting the biotech industry (in Europe, definitely. Monsanto is no longer selling GM corn in France and BASF has moved its biotech operations to the U.S.).
- Not-labeling will stimulate the organic industry (it did!).
- The FDA allows plenty of process labeling (e.g., made from concentrate, irradiated).
- Not-labeling will make the FDA look as if it was in bed with the biotech industry.
- Transparency is always the right thing to do.